Jump to main content

yr 〜
yr

Search results 54

The effect of inertia on brand-name vs. generic drug choice

The effect of inertia on brand-name vs. generic drug choice
Digital博士論文障害者向け資料あり
伊藤, 佑樹伊藤, 佑樹2019
National Diet Library

Selecting better generic drugs

Selecting better generic drugs
Digital博士論文障害者向け資料あり
早川, 正信2015-03-31
National Diet Library

Study on impacts of promotion of generic drug utilization on spontaneous adverse event reports and drug safety assessment at the post-market stage

Study on impacts of promotion of generic drug utilization on spontaneous adverse event reports and drug safety assessment at the post-market stage
Digital博士論文障害者向け資料あり
TAKAMI, Akina2019-03-31
Available onlineNational Diet LibraryOther Libraries in Japan

Contrast between innovator drug-and generic drug-induced renal dysfunction on coronary angiography (CONTRAST study)

Contrast between innovator drug-and generic drug-induced renal dysfunction on coronary angiography (CONTRAST study)
Digital博士論文障害者向け資料あり
中村, 歩2014-03-25
National Diet Library

GE医薬品のFDA認可プロセス : 2008年改定

GE医薬品のFDA認可プロセス : 2008年改定
Paper図書
米国食品医薬品局 製作, サーベイジャパン国際研究所 訳編[サーベイジャパン国際研究所]2008.5<SD81-J16>
National Diet Library

ジェネリック医薬品のFDA認可プロセス

ジェネリック医薬品のFDA認可プロセス
Paper図書
米国食品医薬品局 (FDA) 製作, サーベイジャパン国際研究所 訳編[サーベイジャパン国際研究所]2005.11<SD81-H88>
National Diet Library

How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry (CBO study)

How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry (CBO study)
Microform図書
1998<YCA-Y 10.2:G 28/3>
National Diet Library
  • Subject HeadingGeneric drugs -- Prices -- United States Pre...

Examining issues related to competition in the pharmaceutical marketplace : a review of the FTC report, Generic drug entry prior to patent expiration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, October 9, 2002

Examining issues related to competition in the pharmaceutical marketplace : a review of the FTC report, Generic drug entry prior to patent expiration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, October 9, 2002
Microform図書
2002<YCA-Y 4.C 73/8:107-140>
National Diet Library
  • Subject Heading...ent expiration Generic drugs -- Government policy -- United...

Pharmaceutical patent issues : interpreting GATT : hearings before the Committee on the Judiciary, United States Senate, One Hundred Fourth Congress, second session ... S. 1277, a bill to provide equitable relief for the generic drug industry, and for other purposes, February 27, and March 5, 1996 (S. hrg. ; 104-878)

Pharmaceutical patent issues : interpreting GATT : hearings before the Committee on the Judiciary, United States Senate, One Hundred Fourth Congress, second session ... S. 1277, a bill to provide equitable relief for the generic drug industry, and for other purposes, February 27, and March 5, 1996 (S. hrg. ; 104-878)
Microform図書
1997<YCA-Y 4.J 89/2:S.HRG.104-878>
National Diet Library
  • Subject HeadingPatents (International law) Generic drugs -- Law and legislation -- Unit...

Generic drug substitution : role and function / Keith H. Fukumoto, researcher. (Report)

Generic drug substitution : role and function / Keith H. Fukumoto, researcher. (Report)
Paper図書
Legislative Reference Bureau1990.<AU-1541-A23>
National Diet Library

FDA's generic drug enforcement and approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, March 7 and June 5, 1991

FDA's generic drug enforcement and approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, March 7 and June 5, 1991
Microform図書
1992<YCA-Y 4.En 2/3:102-77>
National Diet Library
  • Subject Heading...uality control Generic drugs -- United States

Generic drug enforcement : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, on H.R. 2454 ... June 26, 1991

Generic drug enforcement : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, on H.R. 2454 ... June 26, 1991
Microform図書
1991<YCA-Y 4.En 2/3:102-45>
National Diet Library

FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session

FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session
Microform図書
1989<YCA-Y 4.En 2/3:101-117>
National Diet Library
  • Subject Heading...Administration Generic drugs -- United States Pharmaceutica...

FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session

FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session
Microform図書
1989<YCA-Y 4.En 2/3:101-115>
National Diet Library
  • Subject Heading...Administration Generic drugs -- United States Pharmaceutica...

Rx for generic drug safety : accurate information for older Americans : hearing before the Subcommittee on Housing and Consumer Interests of the Select Committee on Aging, House of Representatives, One Hundred First Congress, second session, March 1, 1990

Rx for generic drug safety : accurate information for older Americans : hearing before the Subcommittee on Housing and Consumer Interests of the Select Committee on Aging, House of Representatives, One Hundred First Congress, second session, March 1, 1990
Microform図書
1990<YCA-Y 4.Ag 4/2:G 28/2>
National Diet Library
  • Subject HeadingGeneric drugs -- Safety regulations -- Unite...

FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session

FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session
Microform図書
1989<YCA-Y 4.En 2/3:101-220>
National Diet Library
  • Subject Heading...Administration Generic drugs -- United States Pharmaceutica...

FDA's generic drug application policy : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, second session, July 28, 1988

FDA's generic drug application policy : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, second session, July 28, 1988
Microform図書
1989<YCA-Y 4.En 2/3:100-218>
National Diet Library
  • Subject Heading...Administration Generic drugs -- United States Drugs -- Unit...

Generic drug laws : a decade of trial, a prescription for progress / edited by Theodore Goldberg, Carolee A. DeVito, Ira E. Raskin

Generic drug laws : a decade of trial, a prescription for progress / edited by Theodore Goldberg, Carolee A. DeVito, Ira E. Raskin
Microform図書
1986<YCA-HE 20.6502:G 28>
National Diet Library

Competitive problems in the pharmaceutical drug industry : hearing before the Subcommittee on Antitrust, Monopolies [sic], and Business Rights of the Committee on the Judiciary, United States Senate, One Hundredth Congress, first session, on the generic drug industry and its concerns with respect to competition from the brand name manufacturers, October 21, 1987 (S. hrg. ; 100-922)

Competitive problems in the pharmaceutical drug industry : hearing before the Subcommittee on Antitrust, Monopolies [sic], and Business Rights of the Committee on the Judiciary, United States Senate, One Hundredth Congress, first session, on the generic drug industry and its concerns with respect to competition from the brand name manufacturers, October 21, 1987 (S. hrg. ; 100-922)
Microform図書
1989<YCA-Y 4.J 89/2:S.hrg.100-922>
National Diet Library

Generic drug substitution : feasibility for Hawaii / Calvin Azama. (Report - Legislative Reference Bureau ; 1979, no. 1)

Generic drug substitution : feasibility for Hawaii / Calvin Azama. (Report - Legislative Reference Bureau ; 1979, no. 1)
Paper図書
Legislative Reference Bureau1979.<AU-1541-47>
National Diet Library
RSS